Generation of a genetically-modified induced pluripotent stem cell line harboring an oncogenic gene variant KRAS p.G12V

Activating KRAS codon 12 gene variants are known to cause severe RAS-MAPK and PI3K-AKT signaling pathway hyperactivity and are frequently involved in the development of various carcinomas. Here, we describe the generation of a human iPSC line harboring the common oncogenic KRAS p.G12V variant by usi...

Full description

Bibliographic Details
Main Authors: Alexandra Viktoria Busley, Mandy Kleinsorge, Lukas Cyganek
Format: Article
Language:English
Published: Elsevier 2023-06-01
Series:Stem Cell Research
Online Access:http://www.sciencedirect.com/science/article/pii/S1873506123000910
_version_ 1797816008487993344
author Alexandra Viktoria Busley
Mandy Kleinsorge
Lukas Cyganek
author_facet Alexandra Viktoria Busley
Mandy Kleinsorge
Lukas Cyganek
author_sort Alexandra Viktoria Busley
collection DOAJ
description Activating KRAS codon 12 gene variants are known to cause severe RAS-MAPK and PI3K-AKT signaling pathway hyperactivity and are frequently involved in the development of various carcinomas. Here, we describe the generation of a human iPSC line harboring the common oncogenic KRAS p.G12V variant by using CRISPR/Cas9 technology. The established KRASG12V iPSC line allows the study of oncogenic KRAS-induced signaling dysregulation and its impact on cell physiology in various iPSC-derived cell types and tissues. Furthermore, it might serve as a powerful platform for drug and toxicity screenings to identify new chemotherapeutic drugs.
first_indexed 2024-03-13T08:31:18Z
format Article
id doaj.art-d41ae05f63d64ff78da7c1f5e75123a9
institution Directory Open Access Journal
issn 1873-5061
language English
last_indexed 2024-03-13T08:31:18Z
publishDate 2023-06-01
publisher Elsevier
record_format Article
series Stem Cell Research
spelling doaj.art-d41ae05f63d64ff78da7c1f5e75123a92023-05-31T04:44:13ZengElsevierStem Cell Research1873-50612023-06-0169103105Generation of a genetically-modified induced pluripotent stem cell line harboring an oncogenic gene variant KRAS p.G12VAlexandra Viktoria Busley0Mandy Kleinsorge1Lukas Cyganek2Stem Cell Unit, Clinic for Cardiology and Pneumology, University Medical Center Göttingen, Göttingen, Germany; DZHK (German Center for Cardiovascular Research), Partner Site Göttingen, Germany; Cluster of Excellence “Multiscale Bioimaging: from Molecular Machines to Networks of Excitable Cells” (MBExC), University of Göttingen, Germany & Hertha Sponer College, Göttingen, GermanyStem Cell Unit, Clinic for Cardiology and Pneumology, University Medical Center Göttingen, Göttingen, Germany; Institute of Health in der Charité (BIH), Center of Biological Design, Berlin, GermanyStem Cell Unit, Clinic for Cardiology and Pneumology, University Medical Center Göttingen, Göttingen, Germany; DZHK (German Center for Cardiovascular Research), Partner Site Göttingen, Germany; Cluster of Excellence “Multiscale Bioimaging: from Molecular Machines to Networks of Excitable Cells” (MBExC), University of Göttingen, Germany & Hertha Sponer College, Göttingen, Germany; Corresponding author.Activating KRAS codon 12 gene variants are known to cause severe RAS-MAPK and PI3K-AKT signaling pathway hyperactivity and are frequently involved in the development of various carcinomas. Here, we describe the generation of a human iPSC line harboring the common oncogenic KRAS p.G12V variant by using CRISPR/Cas9 technology. The established KRASG12V iPSC line allows the study of oncogenic KRAS-induced signaling dysregulation and its impact on cell physiology in various iPSC-derived cell types and tissues. Furthermore, it might serve as a powerful platform for drug and toxicity screenings to identify new chemotherapeutic drugs.http://www.sciencedirect.com/science/article/pii/S1873506123000910
spellingShingle Alexandra Viktoria Busley
Mandy Kleinsorge
Lukas Cyganek
Generation of a genetically-modified induced pluripotent stem cell line harboring an oncogenic gene variant KRAS p.G12V
Stem Cell Research
title Generation of a genetically-modified induced pluripotent stem cell line harboring an oncogenic gene variant KRAS p.G12V
title_full Generation of a genetically-modified induced pluripotent stem cell line harboring an oncogenic gene variant KRAS p.G12V
title_fullStr Generation of a genetically-modified induced pluripotent stem cell line harboring an oncogenic gene variant KRAS p.G12V
title_full_unstemmed Generation of a genetically-modified induced pluripotent stem cell line harboring an oncogenic gene variant KRAS p.G12V
title_short Generation of a genetically-modified induced pluripotent stem cell line harboring an oncogenic gene variant KRAS p.G12V
title_sort generation of a genetically modified induced pluripotent stem cell line harboring an oncogenic gene variant kras p g12v
url http://www.sciencedirect.com/science/article/pii/S1873506123000910
work_keys_str_mv AT alexandraviktoriabusley generationofageneticallymodifiedinducedpluripotentstemcelllineharboringanoncogenicgenevariantkraspg12v
AT mandykleinsorge generationofageneticallymodifiedinducedpluripotentstemcelllineharboringanoncogenicgenevariantkraspg12v
AT lukascyganek generationofageneticallymodifiedinducedpluripotentstemcelllineharboringanoncogenicgenevariantkraspg12v